Candriam SCA’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1M | Sell |
862,273
-18,157
| -2% | -$254K | 0.07% | 221 |
|
|
2025
Q1 | $11.9M | Buy |
880,430
+149,209
| +20% | +$2.01M | 0.07% | 219 |
|
|
2024
Q4 | $14M | Sell |
731,221
-18,583
| -2% | -$356K | 0.08% | 218 |
|
|
2024
Q3 | $17.1M | Hold |
749,804
| – | – | 0.1% | 204 |
|
|
2024
Q2 | $9.75M | Buy |
749,804
+469,804
| +168% | +$6.11M | 0.06% | 254 |
|
|
2024
Q1 | $4.9M | Buy |
+280,000
| New | +$4.9M | 0.03% | 344 |
|